Journal
BLOOD
Volume 97, Issue 5, Pages 1458-1466Publisher
AMER SOC HEMATOLOGY
DOI: 10.1182/blood.V97.5.1458
Keywords
-
Categories
Funding
- NCRR NIH HHS [M01 RR00043] Funding Source: Medline
- NHLBI NIH HHS [R01 HL54729, 2 R37 HL56067] Funding Source: Medline
- NIAID NIH HHS [R01 AI 34495, P01 AI-35225] Funding Source: Medline
- NICHD NIH HHS [R21 HD37598] Funding Source: Medline
Ask authors/readers for more resources
Hematopoietic stem cell transplantation (HSCT) is followed by profound immunodeficiency. Thymic function is necessary for de novo generation of T cells after HSCT. Circulating CD45RA(+) naive T-cell levels are predictive of antigen-specific T-cell responses in the absence of graft-versus-host disease (GVHD). These T cells may not represent recent thymic emigrants, since naive T cells may maintain this phenotype if not antigen-activated. To accurately measure thymic output after HSCT and determine the factors that influence thymic function, T-cell receptor excision circles (TRECs) were examined in CD4(+) and CD8(+) cells from a cross-section of patients following HSCT. TREC levels rose weeks after HSCT and could be detected in patients 6 years after HSCT. TREC levels correlated with the frequency of phenotypically naive T cells, indicating that such cells were not expanded progeny of naive T cells present in the donor graft. Chronic GVHD was the most important factor that predicted low TREC levels even years after HSCT. Patients with a history of resolved GVHD had decreased numbers of TREC, compared with those with no GVHD. Because few adults had no history of GVHD, it was not possible to determine whether age alone inversely correlated with TREC levels. Recipients of cord blood grafts had no evidence of decreased TREC induced by immunosuppressive prophylaxis drugs. Compared with unrelated donor grafts, recipients of matched sibling grafts had higher TREC levels. Collectively, these data suggest that thymopoiesis is inhibited by GVHD. Larger studies will be needed to determine the independent contributions of age and preparative regimen to posttransplant thymopoietic capacity. (Blood. 2001;91:1458-1466) (C) 2001 by The American Society of Hematology.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available